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Endochondral bone formation is involved in media
calcification in rats and in men
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Arterial media calcification is often considered a
cell-regulated process resembling intramembranous bone
formation, implying a conversion of vascular tissue into a
bone-like structure without a cartilage intermediate. In this
study, we examined the association of chondrocyte-specific
marker expression with media calcification in arterial samples
derived from rats with chronic renal failure (CRF) and from
human transplant donors. CRF was induced in rats with a diet
supplemented with adenine. Vascular calcification was
evaluated histomorphometrically on Von Kossa-stained
sections and the expression of the chondrocyte
markers sox9 and collagen II with the osteogenic marker
core-binding factor alpha1 (cbfa1) was determined
immunohistochemically. Media calcification was detected
in more than half of the rats with CRF. In over half of the rats
with severe media calcification, a typical cartilage matrix
was found by morphology. All of the animals with severe
calcification showed the presence of chondrocyte-like cells
expressing the markers sox9, collagen II, and cbfa1. Human
aorta specimens showing mild to moderate media
calcification also showed sox9, collagen II, and cbfa1
expression. The presence of chondrocytes in association with
calcification of the media in aortas of rats with CRF mimics
endochondral bone formation. The relevance of this
association is further demonstrated by the chondrogenic
conversion of medial smooth muscle cells in the human
aorta.
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Vascular calcification is a major risk factor for cardiovascular
mortality, particularly in patients with end-stage renal
disease1,2 and diabetes.3,4 Calcification may develop in two
distinct layers of the artery, namely the tunica intima and
tunica media. Intima calcification occurs in advanced
atherosclerotic lesions and is associated with lipid accumula-
tion and infiltration of inflammatory cells, such as macro-
phages and T cells. The presence of osteoblasts and
chondrocyte-like cells within calcified atherosclerotic pla-
ques, indicating the formation of structures resembling bone
and cartilage, has been reported in humans5,6 and apoE
knockout mice.7 The observation of cartilage metaplasia in
these lesions provides evidence that intima calcification may
occur at least partially by a process resembling endochondral
bone formation, in which a cartilage template is replaced by
bone.
Media calcification develops independently of athero-
sclerosis and is mainly associated with aging, diabetes, and
end-stage renal disease. In contrast with intima calcification,
calcification in the tunica media is generally believed to
develop analogous to intramembranous osteogenesis, that is,
the direct conversion from condensations of mesenchymal
cells into bone without a cartilage intermediate. Indeed,
several studies have shown that cultured vascular smooth
muscle cells can transdifferentiate into osteoblast-like cells
producing a mineralized matrix and expressing osteogenic
proteins.8–10 In addition, Moe et al.11,12 have demonstrated
the presence of osteoblast-like cells, expressing the osteogenic
transcription factor core-binding factor alpha1 (cbfa1) and
matrix protein collagen I, in the calcified media of the
inferior epigastric artery of uremic patients.
In this study, the process of uremia-related media
calcifications was investigated in rats with adenine-induced
chronic renal failure (CRF), which was demonstrated to be a
useful model for the study of vascular calcification in this
setting.13–15 Cells with the morphological appearance of
chondrocytes in the vicinity of media calcifications were
identified immunohistochemically as chondrocytes, demon-
strating that a process analogous to endochondral bone
formation is an additional mechanism by which media
calcification may develop. In addition, the presence of
chondrocyte-like cells was also demonstrated in the calcified
media of human arteries. To our knowledge, this is the first
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study reporting the localization of chondrocytes in the
calcified tunica media of human arteries in the absence of
atherosclerotic plaque formation.
RESULTS
Experimental study
In this study, rats were fed a diet containing 0.75% adenine
for 4 weeks to induce CRF. Both uremic and control rats were
allocated to two groups receiving a different high phosphate
diet (1.03 or 1.2% phosphate) before and after the adenine
diet (or cellulose diet in the control rats) to achieve optimal
uremia-related vascular calcification (Figure 1). As neither
biochemical parameters nor the degree of vascular calcifica-
tion differed significantly between both high phosphate
groups, biochemical and microscopic results of both groups
were pooled.
Biochemical analysis
Serum and urine parameters are shown in Table 1.
Adenine feeding induced a stable, moderate to severe CRF
as indicated by an increase in the serum creatinine
concentration from 0.4570.06 mg/dl before the start of the
study to 2.6170.52 mg/dl 4 weeks after the start of
adenine treatment. Creatinine levels remained high through-
out the remainder of the study. Renal function impairment
resulted in a significantly decreased urinary phosphate
excretion, and uremic rats also developed hyperphosphate-
mia. After 2 weeks of adenine feeding, serum phosphate
increased significantly to reach maximum values around
16.3578.30 mg/dl at the end of the study. Serum calcium
levels were significantly decreased in CRF rats at week 4 and
remained low until week 10. During the whole study period,
urinary calcium excretion was lower in the CRF group
compared to control rats, reaching significant decreases at 2,
8, and 10 weeks after CRF induction. Adenine-induced CRF
caused a major increase in parathyroid hormone levels
achieving values up to 20407636 pg/ml at week 10,
indicating the development of severe hyperparathyroidism.
Aortic calcification
Evaluation of media calcifications in the aorta showed a large
biological variability, going from no calcification to focal,
partial, or circumferential mineralization in aortic cross-
sections. Overall, 56% of uremic rats developed calcifications
in the tunica media. A good correlation was found between
microscopic (Von Kossa staining) and biochemical (total
calcium content) measurements of vascular calcification
(rs¼ 0.83, Po0.01). The area % vessel calcification and the
calcium content in the aorta did not differ between uremic
rats killed at week 6, 8, or 10 (data not shown), indicating
that vascular calcification developed mainly before week 6
and that the degree of calcification did no longer increase
significantly between weeks 6 and 10.
To correlate the amount of mineral deposition in the
media with the expression of the chondrocyte markers, all
adenine-treated rats were divided into four groups according
to the degree of media calcification: (1) severe calcification,
(2) moderate calcification, (3) mild calcification, and (4) no
calcification. The area % media calcification as well as the
calcium content in the aorta is presented in Table 2. Twelve
out of 39 uremic rats had severe media calcification with an
area Von Kossa positivity of on average 22.0878.36% and
calcium content of 35.77720.63 mg/g wet tissue. Animals
with a few partially calcified aortic sections (moderate
calcification) showed a calcified area of 2.0771.07% and
calcium concentrations of 1.1570.64 mg/g. Five animals
showed mild calcification as indicated by some focal
calcification spots in the media (calcified area: 0.2870.14%;
Table 1 | Serum and urine biochemistry
Pre-CRF 2-week CRF 4-week CRF 6-week CRF 8-week CRF 10-week CRF 10-week CTL
Serum Creatinine (mg/dl) 0.4570.06 1.9370.50b 2.6170.52b 2.2770.46b 2.0070.47b 2.6070.71b 0.5370.06
Phosphate (mg/dl) 6.4770.60 8.5271.86b 9.2071.83b 7.8872.01b 8.1771.06b 16.3578.30b 6.2670.76
Calcium (mg/dl) 6.8270.98 5.9371.26 5.2771.24b 4.5270.98b 4.0571.22b 4.8671.89b 8.2570.50
PTH (pg/ml) ND ND ND 18207438c 20187426c 20407636c 228789
Urine Phosphate (mg/24 h) 173.9726.4a 23.8713.7b 18.978.7b 26.778.2b 38.9716.5b 36.2716.1b 102.5733.8
Calcium (mg/24 h) 1.0870.45a 0.9770.44a 0.8570.42 1.5270.56 1.0470.46a 0.6870.37a 1.2570.50
CRF, chronic renal failure; CTL, values of control; ND, not done.
Serum and urine parameters were determined before the start of the study and every 2 weeks after CRF induction. CTL rats at week 10 are shown in the last column.
aPo0.05 vs control rats at the same time point.
bPo0.001 vs control rats at the same time point.
cPo0.002 vs control rats at week 10.
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Figure 1 | Study setup. Animals were fed a 0.75% adenine diet
for 4 weeks to induce CRF. Before and after the adenine treatment
period (or cellulose in controls), rats were loaded with a high
phosphate diet, either 1.03% P (black bars) or 1.2% P (hatched bars).
CRF rats were killed at week 6, 8, or 10. Control animals (CTL)
were killed at week 10.
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calcium content: 0.3970.15 mg/g). The calcium concentration
in the aorta of uremic rats without development of media
calcifications was comparable with control rats.
Presence of chondrocyte-like cells in severely calcified aortas
Adjacent to media calcifications, cells with the morphological
appearance of chondrocytes were observed in 7/12 animals with
severe media calcifications (Figure 2a). At higher magnification
(Figure 2b), these cells were surrounded by a typical lacuna and
cartilage capsule. At some sites, the matrix, in which these
chondrocyte-like cells were located, was mineralized.
To identify these cells, we performed immunohistochemical
stainings for two specific chondrocyte markers, the transcrip-
tion factor sox9 and the chondrocyte-specific matrix protein
collagen II. As shown in Figure 3, both sox9 (Figures 3b and f)
and collagen II (Figure 3c and g) were highly expressed in these
chondrocyte-like cells. In addition, the osteogenic transcription
factor cbfa1 also stained positive (Figure 3d and h).
The relationship between the expression of the chondro-/
osteogenic markers and the degree of media calcification was
further investigated. An animal was considered positive for a
particular marker when at least two cross-sections stained
positive. Immunohistochemical investigation revealed that all
animals with severe calcification in the aorta showed expression
of sox9 and cbfa1 and 83% of this group also expressed
collagen II. Only one out of five animals with moderate media
calcification was positive for the expression of sox9 or cbfa1.
No expression of these markers was found in aortic sections of
uremic rats with mild calcification and rats with normal renal
function. However, the transcription factor sox9 was also highly
expressed in one noncalcifying uremic animal.
To study the role of apoptosis in the process of media
calcification, apoptotic cells were examined in the rat aorta.
In 9/12 animals with a severely calcified aorta, a few
apoptotic cells were present in the vicinity of calcium
depositions. In four out of these, a number of cells
resembling hypertrophic chondrocytes, which are located in
areas with the morphological appearance of cartilage tissue,
were apoptotic (data not shown). No apoptotic cells were
found in CRF animals with moderate, mild, or no media
calcification and control animals.
Presence of chondrocyte-like cells in human arteries with
media calcification
To examine the presence of chondrocyte-like cells in the
calcified tunica media of human arteries, immunohistochem-
istry for the expression of sox9, collagen II, and cbfa1 was
performed on aortic sections of seven transplant donors.
In three vessels, no intima or media calcification was
detectable on Von Kossa-stained sections (Figure 4a). These
noncalcified vessels showed no or very weak, scattered expres-
sion of sox9 (Figure 4b), and no expression of collagen II
(Figure 4c) and cbfa1 (Figure 4d) could be detected.
Four aorta specimens showed mild to moderate calcifica-
tion in the tunica media (Figure 4e and i), but none of these
vessels had atherosclerotic plaques or intima calcification.
Both the chondrocyte-specific markers sox9 (Figure 4f and j)
and collagen II (Figure 4g and k) and the osteogenic
transcription factor cbfa1 (Figure 4h and l) were highly
expressed in the tunica media of these vessels, both in direct
proximity of mineral deposition (Figure 4i) and in areas
without calcification (Figure 4e).
DISCUSSION
This study demonstrates the localization of chondro-
cyte-like cells adjacent to media calcifications in rats with
a b
Lumen
Lumen
Figure 2 | Presence of chondrocyte-like cells in a Von Kossa-stained cross-section of a rat aorta with severe, circumferential media
calcification. Sections were counterstained with hematoxylin and eosin. (a) A band of tissue with the morphological appearance of cartilage
(arrows) is present at the luminal side of the calcified area. Original magnification  50. (b) Higher magnification of the boxed area in (a) shows
chondrocyte-like cells surrounded by a lacuna (arrowheads) and cartilage capsule (arrows). Original magnification  320.
Table 2 | Evaluation of media calcifications in the aorta
Degree of
calcification
Number of
animals
Area %
calcification
mg Ca/g
wet tissue
Severe 12 22.0878.36 35.77720.63
Moderate 5 2.0771.07 1.1570.64
Mild 5 0.2870.14 0.3970.15
None – CRF rats 17 0.0670.01 0.2070.06
None – control rats 16 0.0070.00 0.1770.03
CRF, chronic renal failure.
Since the severity of vascular calcification did not correlate with the time of killing,
uremic rats were divided into four groups according to the degree of vascular
calcification. Data are thus from weeks 6, 8, and 10 after onset of chronic renal
failure. For each group, the number of animals, the mean area % vessel calcification,
and the mean calcium content were calculated.
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adenine-induced CRF. Immunohistochemical analysis
showed the expression of two specific chondrocyte markers,
that is the transcription factor sox9 and the cartilage matrix
protein collagen II, in severely calcified rat aortas. Sox9 is a
crucial regulator in the early steps of the chondrocyte
differentiation pathway.16,17 It regulates the conversion of
mesenchymal cells to chondroprogenitors and the establish-
ment of the chondrogenic mesenchymal condensations
during endochondral bone formation, and promotes the
expression of downstream proteins, such as collagen II. In
severely calcified aortas, a large subset of cells positive for
sox9 and/or collagen II also expressed the osteogenic
transcription factor cbfa1. The latter protein is required for
osteoblast differentiation,18,19 but is also expressed in
hypertrophic chondrocytes in the growth plate.20–22 The
expression of cbfa1 in arterial smooth muscle cells is mostly
considered a transdifferentiation towards osteoblast-like cells,
but in this study, the co-expression of both specific
chondrocyte markers together with cbfa1 in the same cell,
as shown in Figure 3, indicates that cells with the phenotype
of hypertrophic chondrocytes are present in the tunica media
of calcifying vessels.
This is the first study reporting the involvement of
cartilage metaplasia in the process of media calcification in
the setting of CRF. These findings are in line with previous
gene knockout studies showing the expression of collagen II
in association with media calcification in mice lacking matrix
Gla protein,23 an inhibitor of vascular calcification, and mice
lacking PC-1/nucleotide pyrophosphatase phosphodiester-
ase 1,24 an enzyme that generates the calcification inhibitor
pyrophosphate. In addition, chondrocyte-like cells expressing
S100 protein were found in the calcified media of aortic rat
allografts.25 Our observations together with these experi-
mental studies imply that media calcification may proceed at
least partially through a process similar to endochondral
bone formation. Strikingly, this is in contrast to what has
been reported in recent reviews,26–29 stating that endochon-
dral ossification is involved in intimal plaque calcification,
whereas media calcification is described as a process in which
vascular tissue develops directly towards a bone structure,
without a cartilage intermediate.
Chondrocyte-like cells, highly expressing sox9 and col-
lagen II, were further localized in human arteries with mild to
moderate media calcifications, strengthening the clinical
relevance of the above experimental findings and suggesting
that chondrogenic conversion of arterial smooth muscle cells
during media calcification is more important than believed
previously. Shanahan et al.30 used reverse transcription-
polymerase chain reaction to demonstrate a significant
increase in collagen II expression in human peripheral
arteries of diabetic patients with Mo¨nckeberg’s sclerosis. As
RNA was extracted from sections of the whole vessel and
intimal plaque formation/calcification was also present in
these arteries, no conclusions could be drawn concerning the
localization of the chondrocyte-like cells. A few years ago, a
case report of two diabetic patients with renal failure
described cartilaginous metaplasia in intimal plaque tissue
and the tunica media of lower extremity arteries with
extensive intima and media calcifications.6 In extension to
these findings, this study reports the localization of an early
(sox9) and late (collagen II) chondrocyte marker associated
with mild to moderate media calcifications in arteries with
no accompanying atherosclerosis, obtained from transplant
donors representing relatively healthy humans.
In adenine-induced CRF rats, chondrocyte-like cells were
mainly present in severely calcified aortas, which may suggest
that endochondral ossification plays a role in a later stage of
the calcification process, when massive hydroxyapatite
depositions are already present in the media. However, sox9
was also highly expressed in one noncalcifying uremic rat
and, more importantly, both chondrocyte-specific markers
were abundantly expressed in human arteries with only mild
media calcifications and in noncalcified areas of human
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Figure 3 | Immunohistochemical evidence for the presence of
chondrocyte-like cells in the calcified tunica media. Aortic
cross-sections of the same area from a CRF rat killed at week 10 (a–d)
and week 8 (e–h). Original magnification  160. (a) and (e) Von Kossa
staining shows severe calcification in the media. (b and f) Sox9,
(c and g) collagen II, and (d and h) cbfa1 are highly expressed in cells
with the morphological appearance of chondrocytes.
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vessels with moderate media calcification. This refutes the
above assumption and indicates that chondrocytes and a
process analogous to endochondral bone formation also
contribute to the initial phase of media calcification. A
possible explanation for the absence of chondrocyte-like cells
in rats with mild media calcifications may be that uremia-
induced media calcifications in the rat seems to be an ‘all or
none’ phenomenon in which the calcifications develop within
a very short-time period, by which initial steps in this process
may be missed. Experimental studies with the rat model of
adenine-induced CRF performed in our laboratory revealed
that most of the animals either are resistant to vessel
calcification or develop massive-media calcifications over a
2-week time period, that is between weeks 4 and 6 after CRF
induction. It is indeed remarkable that, despite a comparable,
stable, moderate to severe CRF in all animals fed an adenine-
rich diet, only 56% of them developed media calcifications. In
order to explain this high biological variability, which is also
reported in humans,11,31,32 various serum, urine, and bone
parameters relevant to the mineral metabolism were statisti-
cally correlated with the development of vascular calcification.
However, no singular parameter significantly differed between
calcifying and noncalcifying uremic animals, suggesting that a
combination of different factors must be responsible for the
induction of vessel calcification. It is indeed well known that
various inducers, such as phosphate9,10 and calcium,33,34 and
inhibitors, such as matrix Gla protein,23 fetuin A,35,36 and
pyrophosphate,37 and the balance between both, play an
important role in the calcification process.
As apoptosis has been proposed to initiate the calcification
process in vitro,33,38 we investigated the involvement of
apoptotic cells in media calcifications in vivo. Only a few
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Figure 4 | Presence of chondrocyte-like cells in a human aorta specimen with moderate media calcification. (a–d) Cross-sections of a
human aorta without calcification, (e–h) a noncalcified area at some distance of mineral deposition, and (i–l) a calcified area in a human vessel
with moderate media calcifications. Original magnification  100. (a, e, i) Von Kossa staining; (b, f, j) sox9 immunostaining; (c, g, k) collagen II
immunostaining; (d, h, l) cbfa1 immunostaining. Expression of the three chondro-/osteogenic markers was absent in the noncalcified
aorta specimen (b–d). A noncalcified area (f–h) and a calcified area (j–l) in a vessel with moderate media calcification show high expression
of the chondrocyte-specific markers sox9, collagen II, and the osteogenic transcription factor cbfa1.
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apoptotic cells could be detected in the vicinity of
severely calcified areas in arteries of uremic rats. Interestin-
gly, some morphologically distinguishable hypertrophic
chondrocytes in the media were apoptotic. This is in
agreement with the fate of hypertrophic chondrocytes in
the epiphyseal growth plate during endochondral bone
formation, where they either undergo apoptosis39–42 or
transdifferentiate to osteoblasts,43,44 which replace the
cartilage matrix by bone (reviewed by Archer and Francis-
West45). Analogous to endochondral bone formation, it is
possible that hypertrophic chondrocyte-like cells in the vessel
wall also undergo either of these processes and in this way
contribute to the mechanism of media calcification. How-
ever, further investigation is necessary to confirm this
hypothesis.
In conclusion, the presence of chondrocyte-like cells in
association with media calcification in both rat and human
arteries indicates that, in addition to intramembranous
ossification, a process resembling endochondral bone forma-
tion is another mechanism by which media calcification may
occur. As previously reported, osteoblast-like cells are also
involved in media calcification. In our study, the osteoblast
markers collagen I, osteopontin, and bone sialoprotein were
found to be associated with calcified areas (Neven et al., J Am
Soc Nephrol 2006; 17: 506A), suggesting that intramembra-
nous bone formation can also play an important role in the
process of media calcification in this animal model. However,
it remains unclear to what extent each of the processes
contributes to the development of media calcification.
Finally, this study contributes to a better understanding of
the cellular mechanisms involved in vessel calcification,
which is important for future therapeutic intervention
studies.
MATERIALS AND METHODS
Experimental study
Study design. Male Wistar rats (Iffa Credo, Brussels, Belgium)
were purchased at 10 weeks of age and housed in plastic cages
at constant room temperature with a 12-h light/dark cycle and
with tap water and food available ad libitum. All experimental
procedures were conducted according to the National Institutes of
Health Guide for the Care and Use of Laboratory Animals 85-23
(1996) and approved by the Antwerp University Ethics Committee.
The study set-up is presented in Figure 1. In order to assess optimal
conditions for uremia-related media calcifications, two different
high phosphate diets (SSNIFF Spezialdia¨ten, Soest, Germany) were
used. Before the start of the study, animals were conditioned on the
respective high phosphate diets (1.06% calcium and 1.03 or 1.2%
phosphate) for 2 weeks. Moderate to severe CRF was induced by
feeding rats a diet containing 0.75% adenine (0.92% phosphate and
1.0% calcium) for 4 weeks, after which the animals were again
administered the high phosphate diet until killing after 6, 8, or 10
weeks of CRF. Control animals received 0.75% cellulose instead of
the adenine-enriched diet and were killed at week 10. Before
induction of CRF and every 2 weeks until killing, animals were
placed in metabolic cages for 24 h urine collection, followed by
blood sampling from the tail vein. Serum and urine samples were
stored at 801C until further analysis.
At killing, animals were exsanguinated through the retro-orbital
plexus after anesthesia with sodium pentobarbital 60 mg/kg via
intraperitoneal injection.
Serum and urine biochemistry. Serum creatinine, calcium,
and phosphorus were measured using the Vitros 750 XRC
autoanalyzer system. Urinary creatinine was measured with a
colorimetric method (Creatinine Merckotest, Diagnostica Merck,
Germany). Urinary calcium was determined with flame atomic
absorption spectrometry (Perkin-Elmer, Wellesley, MA, USA) and
urinary phosphorus was measured with the EcolinesS Phosphate
kit (DiaSys, Holzheim, Germany). Serum parathyroid hormone was
measured with a rat PTH-IRMA kit (Immutopics Inc., San
Clemente, CA, USA) according to the manufacturer’s instructions.
Evaluation of vascular calcification in the aorta. At killing,
the aorta was dissected out. The aortic arch and the proximal
thoracic aorta were fixed in neutral buffered formalin and cut into
2–3 mm rings before embedding. All rings from the same aorta were
embedded upright in the same paraffin block, so that every section
comprises on average eight to nine cross-sections (minimum six) at
different sites along the vessel. Four micrometer sections were
stained for calcification with Von Kossa’s method and counter-
stained with hematoxylin and eosin. Vascular calcifications were
evaluated histomorphometrically on Von Kossa-stained sections
with the Kontron 400 2.0 image analysis software (Kontron,
Nashville, TN, USA). Sections were analyzed at magnification
 100 with two different color separation thresholds, one to measure
the area % of the slide covered with tissue, and another to measure
the area % of Von Kossa positivity. The possibility for manual user
intervention was built into the program to eliminate artefacts
outside the aorta, which falsely increase the tissue area, and tissue
folds, which can give rise to overestimation of the calcified tissue
area. The absolute areas of tissue and calcified tissue were summed
for each animal and the ratio is expressed as area % aortic
calcification. For noncalcifying animals, two microscopic fields were
measured per cross-section, whereas in calcifying animals all cross
sections were analyzed completely. The distal part of the thoracic
aorta was used to determinate the total calcium content. Therefore,
tissue samples were weighed shortly after removal, subsequently
digested in 65% nitric acid at 651C overnight and diluted in 0.1%
lanthanum nitrate to eliminate chemical interference during total
calcium content measurement with flame atomic absorption
spectrometry (Perkin-Elmer, Wellesley, MA, USA). Results are
expressed as mg calcium/g wet tissue. Calcifying animals were
allocated to three groups according to the degree of calcification.
Animals with an area % Von Kossa positivity X5 were considered
to have severe media calcification. Those with a calcified area
between 1 and 5% were classified as moderate media calcification
and those with values between 0.1 and 1% to have mild media
calcification.
Apoptosis
Apototic cells were examined by the TUNEL assay (ApopTags
Peroxidase In situ Apoptosis Detection Kit, Chemicon International,
Temecula, CA, USA) according to the manufacturer’s instructions,
omitting the pre-treatment step with proteinase K. Instead, the
sections were decalcified in 3% citric acid for 1 h at room
temperature before starting the protocol. A cross-section of a
calcified rat aorta, pre-treated with DNAse I in a concentration of
1000 U/ml for 30 min at 371C, was used as a positive control. Cross-
sections were counterstained with hematoxylin and analyzed by light
microscopy at original magnification  1000.
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Human tissue
Aorta specimens were obtained from seven transplant donors with
normal kidney function, after approval by the Antwerp University
Ethics Committee. The tissue was fixed in neutral buffered formalin
or formol calcium and embedded in paraffin. Calcification in the
vessel wall was stained with Von Kossa’s method. Four micrometer
serial sections were cut for immunohistochemical analysis of sox9,
collagen II, and cbfa1.
Immunohistochemistry
Immunohistochemical stainings for sox9, collagen II, and cbfa1 were
performed on aortic sections of both rats and humans with goat
polyclonal antibodies against the human antigen, showing a good
crossreactivity in rat tissue. Chondrocytes were identified by the
expression of the transcription factor sox9 (sc-17340) and
chondrocyte-specific matrix protein collagen II (sc-7764) (Santa
Cruz Biotechnology, CA, USA). Sections were also incubated with a
primary antibody against the osteogenic transcription factor cbfa1
(sc-8566, Santa Cruz Biotechnology). For all immunohistochemical
stainings, a biotinylated horse anti-goat immunoglobulin G (Vector
Laboratories, Burlingame, CA, USA) was used as secondary
antibody. Subsequently avidin and biotinylated horseradish peroxi-
dase (VECTASTAINs ABC KIT, Vector Laboratories) were added as
signal amplifiers. 3-Amino-9-ethylcarbazole (AEC, Sigma-Aldrich,
Bornem, Belgium) was used as chromogen. Sections of human
cartilage were included as positive controls for the chondrocyte
markers. Sections in which the primary antibody was omitted served
as negative controls.
Statistics
Data are expressed as mean7s.d. Statistical analysis was performed
with SPSS 12.0 for Windows software. Differences between CRF and
control animals were assessed for each time point with a
Mann–Witney U-test, in combination with Bonferroni correction
when multiple comparisons were made. A Kruskal–Wallis test was
used when more than two groups were compared. A value of
Po0.05 was considered significant. The Spearman Correlation
Coefficient (rs) was used to evaluate the correlation between the
biochemical and histomorphometric results of media calcification.
The correlation is significant when Po0.01.
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